Medpace Holdings, Inc. Share Price & Technical Analysis
MEDP · $432.8 (+0.63%)
Healthcare / Diagnostics & Research
$432.8
+0.63%
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
3% return in May, 0% avg return in past 3 year May month.
-19% return in 2026, 39% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 4% | -22% | 8% | -13% | 3% | – | – | – | – | – | – | – | -19% |
| 25 | 4% | -5% | -7% | 1% | -4% | 7% | 36% | 12% | 8% | 14% | 1% | -5% | 63% |
| 24 | -4% | 36% | 2% | -4% | 0% | 5% | -8% | -7% | -6% | -6% | 8% | -2% | 13% |
| 23 | 4% | -13% | -3% | 7% | 3% | 16% | 5% | 7% | -11% | 0% | 12% | 13% | 40% |
| 22 | -18% | -14% | 7% | -19% | 8% | 4% | 14% | -13% | 8% | 41% | -4% | 1% | 14% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$11.92B
P/E ratio
26.24
52W high
$628.9
52W low
$291.3
Volume
2,33,227
Beta
1.19
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Medpace Holdings, Inc. share price today?
- Medpace Holdings, Inc. (MEDP) last traded around $432.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MEDP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MEDP. Download the app for real-time alerts.
- How can I analyze Medpace Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.